RBC Europe’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,050
| Closed | -$36.4K | – | 633 |
|
|
2021
Q3 | $36.4K | Hold |
7,050
| – | – | ﹤0.01% | 647 |
|
|
2021
Q2 | $30K | Buy |
+7,050
| New | +$30K | ﹤0.01% | 715 |
|
|
2019
Q3 | – | Sell |
-600
| Closed | -$2.41K | – | 1057 |
|
|
2019
Q2 | $2.41K | Hold |
600
| – | – | ﹤0.01% | 973 |
|
|
2019
Q1 | $2.58K | Hold |
600
| – | – | ﹤0.01% | 980 |
|
|
2018
Q4 | $3.45K | Hold |
600
| – | – | ﹤0.01% | 954 |
|
|
2018
Q3 | $8.14K | Hold |
600
| – | – | ﹤0.01% | 886 |
|
|
2018
Q2 | $7.12K | Hold |
600
| – | – | ﹤0.01% | 913 |
|
|
2018
Q1 | $6.74K | Hold |
600
| – | – | ﹤0.01% | 910 |
|
|
2017
Q4 | $4.01K | Hold |
600
| – | – | ﹤0.01% | 993 |
|
|
2017
Q3 | $4.91K | Buy |
+600
| New | +$4.91K | ﹤0.01% | 952 |
|